Notice of Clarification to Research Strategy Instructions in PAR-16-300 "Clinical Coordinating Center for Multi-Site Investigator-Initiated Clinical Trials (Collaborative UG3/UH3)"

Notice Number: NOT-HL-16-338

Key Dates
Release Date:   August 15, 2016

Related Announcements
PAR-16-300    

Issued by
National Heart, Lung, and Blood Institute (NHLBI)

Purpose

On May 31, 2016, the NHLBI issued Funding Opportunity Announcement (FOA) PAR-16-300 "Clinical Coordinating Center for Multi-Site Investigator-Initiated Clinical Trials (Collaborative UG3/UH3)". The purpose of this Notice is to clarify that it is acceptable to provide all information requested for the Recruitment and Retention Plan in a single table. The following section of the FOA is revised accordingly:

Part 2. Section IV. 2. Content and Form of Application Submission

PHS 398 Research Plan

Research Strategy

Current Language
A Recruitment and Retention Plan consisting of two tables: a table of the recruiting sites and site PDs/PIs, and a table showing enrollment goals and number of potential participants available at each site.

Revised Language
A Recruitment and Retention Plan consisting of two tables or a single combined table with the following information: 1) the recruiting sites and site PDs/PIs, and 2) enrollment goals and number of potential participants available at each site.

All other aspects of the FOA remain unchanged.

Inquiries

Please direct all inquiries to:

Keary Cope, PhD
National Heart, Lung, and Blood Institute (NHLBI)
Telephone: 301-435-0287
Email: copeka@nhlbi.nih.gov